Intervention Review

You have free access to this content

Vitamin A supplementation for cystic fibrosis

  1. Catherine M Bonifant1,*,
  2. Elizabeth Shevill2,
  3. Anne B Chang3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 14 MAY 2014

Assessed as up-to-date: 6 MAY 2014

DOI: 10.1002/14651858.CD006751.pub4


How to Cite

Bonifant CM, Shevill E, Chang AB. Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD006751. DOI: 10.1002/14651858.CD006751.pub4.

Author Information

  1. 1

    Royal Children's Hospital, Department of Nutrition and Dietetics, Herston, Queensland, Australia

  2. 2

    Royal Children's Hospital, Department of Respiratory Medicine, Herston, Queensland, Australia

  3. 3

    Menzies School of Health Research, Charles Darwin University, Child Health Division, Darwin, Northern Territories, Australia

*Catherine M Bonifant, Department of Nutrition and Dietetics, Royal Children's Hospital, Lower Ground Floor, South Tower, Herston Road, Herston, Queensland, 4029, Australia. Catherine_Bonifant@health.qld.gov.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 MAY 2014

SEARCH

 
Characteristics of excluded studies [ordered by study ID]

StudyReason for exclusion

Wood 2003Non-placebo controlled trial. This trial examined outcomes of 46 CF patients randomly assigned to either group A [low dose of supplement (10 mg vitamin E and 500 micro g vitamin A)] or group B [high dose of supplement (200 mg vitamin E, 300 mg vitamin C, 25 mg beta-carotene, 90 micro g Se, and 500 micro g vitamin A)].